Drugs News and Research

RSS

Harvard researchers unite in fight against antibiotic resistance

The National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) have awarded $5 million to an interdisciplinary group of Harvard researchers to launch the "Harvard-wide Program on Antibiotic Resistance."

14 Oct 2009

Researchers discover compounds that show promise as novel treatments for AIDS

While studying an HIV protein that plays an essential role in AIDS progression, researchers at the University of Pittsburgh School of Medicine have discovered compounds that show promise as novel treatments for the disease.

14 Oct 2009

SCID infants who receive early bone marrow transplants are likely to have fewer complications

Mention the words "bubble boy" and many will recall David Vetter, the kid with big eyes and a thick thatch of dark hair who died 25 years ago after spending almost the entire 12 years of his life in a germ-free, plastic bubble. David was born with severe combined immune deficiency, or SCID, a condition that robbed him of an immune system.

14 Oct 2009

Decreased expression of tumor suppressor gene PTEN transforms neurofibromas into cancer

Researchers at UCLA's Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called neurofibromas into a malignant and extremely deadly form of sarcoma.

14 Oct 2009

Cequent Pharmaceuticals to provide details of its clinical program at BIOCOM conference

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference.

14 Oct 2009

New UCL cancer research centre launched in UK

A new centre is launched in London today (Wednesday), joining a select group of Cancer Research UK Centres across the UK.

14 Oct 2009

Seniors and people with disabilities to choose new healthcare coverage

More than 600,000 seniors and people with disabilities will be required to choose new healthcare coverage during the upcoming Medicare annual enrollment because their current plan is being eliminated. However, millions more could benefit by changing to a plan that better fits their needs, according to Allsup, a nationwide provider of Social Security disability representation and Medicare services.

14 Oct 2009

Champions Biotechnology receives U.S. patent for its tubulin inhibitors

Champions Biotechnology, Inc., a drug development company with a preclinical platform able to predict clinical effectiveness, accelerate development and enhance the value of oncology drugs, today announced that the United States Patent and Trademark Office issued a patent on September 29, 2009 for the company's tubulin inhibitors, including its lead compound SG410.

14 Oct 2009

OPKO Health signs agreement with Schering-Plough to acquire assets relating to NK-1 program

OPKO Health, Inc. today announced that it has entered into a definitive agreement with Schering-Plough Corporation to acquire assets relating to Schering’s neurokinin-1 (NK-1) receptor antagonist program. Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.

14 Oct 2009

Galapagos extends collaboration with Merck to develop new therapies for atherosclerosis

Galapagos NV announced today that it has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck & Co., Inc to incorporate the development of new therapies for atherosclerosis.

14 Oct 2009

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.

14 Oct 2009

Decision Resources: Rheumatoid arthritis drug market in India to grow up to $672 million in 2013

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.

14 Oct 2009

Ahura Scientific expands global customer base in China and Germany

Ahura Scientific, Inc., the leader in field-deployed analytical instruments for human health and public safety, today announced an upgrade to the language capabilities of TruScan, its handheld Raman spectrometer designed for the stringent requirements of the pharmaceutical and consumer health industries.

14 Oct 2009

Unapproved codeine sulfate tablets: FDA warns four companies to stop marketing

The U.S. Food and Drug Administration today warned four companies that they must stop marketing unapproved codeine sulfate tablets. These drugs are opioid analgesics, commonly called narcotics, that are widely used to treat pain.

14 Oct 2009

African leaders, Chirac unite to fight fake drug manufacturing, distribution

Leaders from Benin, Burkina Faso, the Central African Republic, Congo-Republic, Niger and Senegal on Monday joined former French President Jacques Chirac in Cotonou, Benin, in a campaign against the manufacturing and sale of fake pharmaceutical products, Reuters reports (Lewis, 10/12).

14 Oct 2009

Prescription drug ads drive up U.S. health costs

NPR reports on how prescription drug advertising drives up consumer demand, which drives up medical costs. The story, done in partnership with the public radio program, This American Life, is the third in a three-part series about why American health care costs are so high. "Prescription drug spending is the third most expensive cost in the U.S. health care system.

13 Oct 2009

USAID awards Abt Associates 'Strengthening Health Outcomes Through Private Sector' grant

The United States Agency for International Development (USAID) has awarded a five-year grant, Strengthening Health Outcomes through the Private Sector, to Abt Associates, Inc. Sub-recipients under the grant are Banyan Global, Jhpiego, Marie Stopes International, the Monitor Group, and O'Hanlon Health Consulting, LLC.

13 Oct 2009

Sequella receives Phase 1 SBIR grant for developing SQ641

Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.

13 Oct 2009

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic findings in the fields of obesity and osteoporosis at medical meetings later this month.

13 Oct 2009

Provectus Pharmaceuticals completes initial treatment in Phase 2 trial of PH-10 for plaque psoriasis

Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.

13 Oct 2009

Drugs News and Research

Harvard researchers unite in fight against antibiotic resistance

Researchers discover compounds that show promise as novel treatments for AIDS

SCID infants who receive early bone marrow transplants are likely to have fewer complications

Decreased expression of tumor suppressor gene PTEN transforms neurofibromas into cancer

Cequent Pharmaceuticals to provide details of its clinical program at BIOCOM conference

New UCL cancer research centre launched in UK

Seniors and people with disabilities to choose new healthcare coverage

Champions Biotechnology receives U.S. patent for its tubulin inhibitors

OPKO Health signs agreement with Schering-Plough to acquire assets relating to NK-1 program

Galapagos extends collaboration with Merck to develop new therapies for atherosclerosis

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Decision Resources: Rheumatoid arthritis drug market in India to grow up to $672 million in 2013

Ahura Scientific expands global customer base in China and Germany

Unapproved codeine sulfate tablets: FDA warns four companies to stop marketing

African leaders, Chirac unite to fight fake drug manufacturing, distribution

Prescription drug ads drive up U.S. health costs

USAID awards Abt Associates 'Strengthening Health Outcomes Through Private Sector' grant

Sequella receives Phase 1 SBIR grant for developing SQ641

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

Provectus Pharmaceuticals completes initial treatment in Phase 2 trial of PH-10 for plaque psoriasis

Drug Discovery - Second Edition eBook

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Latest News